SCHEMBL16985170

SCHEMBL16985170

O=C(ON1C(=O)CCC1=O)c1cc(=O)oc2cc(O)c(Cl)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 6/20 0.49
▸ TDP1 Q9NUW8 1/20 0.45
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ ERAP1 Q9NZ08 1/20 0.42
▸ LMNA P02545 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ NCOA2 Q15596 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ NCOR2 Q9Y618 1/20 0.39
▸ KDM4E B2RXH2 6/20 0.36
▸ HTT P42858 2/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ HPGD P15428 4/20 0.35
▸ HSD17B10 Q99714 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13180172 0.81 TDP1 (0.54) MCL1TDP1MEN1KMT2AERAP1
SCHEMBL13494166 0.78 GPR35 (0.41) MEN1KMT2ALMNAPPARGNCOA2
SCHEMBL3085227 0.76 MCL1 (0.59) MCL1TDP1MEN1KMT2AERAP1
SCHEMBL31114272 0.71 MAOB (0.37) MEN1KMT2AKDM4EGLAGAA
SCHEMBL12714431 0.67 ESR1 (0.40) —
SCHEMBL12038347 0.67 GLA (0.38) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL4136788 0.67 CYP2A6 (0.42) MCL1TDP1MEN1KMT2ALMNA
SCHEMBL31357189 0.67 MCL1 (1.00) MCL1TDP1MEN1KMT2AERAP1
SCHEMBL2552748 0.67 MCL1 (1.00) MCL1TDP1MEN1KMT2AERAP1
SCHEMBL14680363 0.66 SMN1; SMN2 (0.47) KMT2AKDM4EGAAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10401361-B2 Intracellular organelle peptide targeted enzyme substrates MARKER GENE TECHNOLOGIES, INC. (US) 2019-09-03 — — US disclosed
US-20180120317-A1 INTRACELLULAR ORGANELLE PEPTIDE TARGETED ENZYME SUBSTRATES MARKER GENE TECHNOLOGIES, INC. 2018-05-03 — — US disclosed
US-20180120317-A1 INTRACELLULAR ORGANELLE PEPTIDE TARGETED ENZYME SUBSTRATES MARKER GENE TECHNOLOGIES, INC. 2018-05-03 — — US disclosed
US-9841426-B2 Intracellular organelle peptide targeted enzyme substrates MARKER GENE TECHNOLOGIES, INC (US) 2017-12-12 — — US disclosed
US-9841426-B2 Intracellular organelle peptide targeted enzyme substrates MARKER GENE TECHNOLOGIES, INC (US) 2017-12-12 — — US disclosed
US-20150219654-A1 INTRACELLULAR ORGANELLE PEPTIDE TARGETED ENZYME SUBSTRATES MARKER GENE TECHNOLOGIES, INC. 2015-08-06 — — US disclosed
US-20150219654-A1 INTRACELLULAR ORGANELLE PEPTIDE TARGETED ENZYME SUBSTRATES MARKER GENE TECHNOLOGIES, INC. 2015-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10401361-B2 Intracellular organelle peptide targeted enzyme substrates GLG1, GBA3, MIA3 MCL1 3218/4885TDP1 1126/4885MEN1 3784/4885
US-20180120317-A1 INTRACELLULAR ORGANELLE PEPTIDE TARGETED ENZYME SUBSTRATES GLG1, GBA3, MIA3 MCL1 3218/4885TDP1 1126/4885MEN1 3784/4885
US-20150219654-A1 INTRACELLULAR ORGANELLE PEPTIDE TARGETED ENZYME SUBSTRATES GLG1, GBA3, MIA3 MCL1 3218/4885TDP1 1126/4885MEN1 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback